- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About XOMA
XOMA Corporation is a biopharmaceutical company that develops and manufactures genetically engineered protein, peptide, and antibody pharmaceuticals. The Company's medical targets include bacterial and fungal infections, infectious complications, and immunologic and inflammatory disorders. XOMA's primary drug development platform is bactericidal/permeability-increasing protein.
9.61%
4.76%
Stock Analysis
last close
$20.93
1-mo return
-10.2%
3-mo return
-12.1%
avg daily vol.
31.49T
52-week high
44.5
52-week low
19.4
market cap.
$241M
forward pe
12.3
annual div.
-
roe
5.9%
ltg forecast
-
dividend yield
-
annual rev.
$30M
inst own.
60.5%
